• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 - 2019年204个国家和地区嚼烟使用流行情况的空间、时间和人口模式:来自《2019年全球疾病负担研究》的系统分析

Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.

出版信息

Lancet Public Health. 2021 Jul;6(7):e482-e499. doi: 10.1016/S2468-2667(21)00065-7. Epub 2021 May 28.

DOI:10.1016/S2468-2667(21)00065-7
PMID:34051920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8251505/
Abstract

BACKGROUND

Chewing tobacco and other types of smokeless tobacco use have had less attention from the global health community than smoked tobacco use. However, the practice is popular in many parts of the world and has been linked to several adverse health outcomes. Understanding trends in prevalence with age, over time, and by location and sex is important for policy setting and in relation to monitoring and assessing commitment to the WHO Framework Convention on Tobacco Control.

METHODS

We estimated prevalence of chewing tobacco use as part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 using a modelling strategy that used information on multiple types of smokeless tobacco products. We generated a time series of prevalence of chewing tobacco use among individuals aged 15 years and older from 1990 to 2019 in 204 countries and territories, including age-sex specific estimates. We also compared these trends to those of smoked tobacco over the same time period.

FINDINGS

In 2019, 273·9 million (95% uncertainty interval 258·5 to 290·9) people aged 15 years and older used chewing tobacco, and the global age-standardised prevalence of chewing tobacco use was 4·72% (4·46 to 5·01). 228·2 million (213·6 to 244·7; 83·29% [82·15 to 84·42]) chewing tobacco users lived in the south Asia region. Prevalence among young people aged 15-19 years was over 10% in seven locations in 2019. Although global age-standardised prevalence of smoking tobacco use decreased significantly between 1990 and 2019 (annualised rate of change: -1·21% [-1·26 to -1·16]), similar progress was not observed for chewing tobacco (0·46% [0·13 to 0·79]). Among the 12 highest prevalence countries (Bangladesh, Bhutan, Cambodia, India, Madagascar, Marshall Islands, Myanmar, Nepal, Pakistan, Palau, Sri Lanka, and Yemen), only Yemen had a significant decrease in the prevalence of chewing tobacco use, which was among males between 1990 and 2019 (-0·94% [-1·72 to -0·14]), compared with nine of 12 countries that had significant decreases in the prevalence of smoking tobacco. Among females, none of these 12 countries had significant decreases in prevalence of chewing tobacco use, whereas seven of 12 countries had a significant decrease in the prevalence of tobacco smoking use for the period.

INTERPRETATION

Chewing tobacco remains a substantial public health problem in several regions of the world, and predominantly in south Asia. We found little change in the prevalence of chewing tobacco use between 1990 and 2019, and that control efforts have had much larger effects on the prevalence of smoking tobacco use than on chewing tobacco use in some countries. Mitigating the health effects of chewing tobacco requires stronger regulations and policies that specifically target use of chewing tobacco, especially in countries with high prevalence.

FUNDING

Bloomberg Philanthropies and the Bill & Melinda Gates Foundation.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abf/8251505/a97cdffd8703/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abf/8251505/029004de1be1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abf/8251505/9ff5663cf4a4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abf/8251505/a97cdffd8703/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abf/8251505/029004de1be1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abf/8251505/9ff5663cf4a4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abf/8251505/a97cdffd8703/gr3.jpg
摘要

背景

与吸烟相比,嚼烟及其他类型无烟烟草的使用受到全球卫生界的关注较少。然而,这种行为在世界许多地区都很普遍,并且与多种不良健康后果相关。了解年龄、时间、地点和性别方面的流行趋势对于政策制定以及监测和评估对《世界卫生组织烟草控制框架公约》的承诺至关重要。

方法

作为2019年全球疾病、伤害及风险因素负担研究的一部分,我们采用一种建模策略估计嚼烟使用的流行率,该策略使用了多种无烟烟草产品的信息。我们生成了1990年至2019年204个国家和地区15岁及以上人群嚼烟使用流行率的时间序列,包括按年龄和性别的具体估计值。我们还将这些趋势与同一时期吸烟的趋势进行了比较。

结果

2019年,15岁及以上人群中有2.739亿人(95%不确定区间为2.585亿至2.909亿)使用嚼烟,全球年龄标准化嚼烟使用率为4.72%(4.46%至5.01%)。2.282亿(2.136亿至2.447亿;83.29%[82.15%至84.42%])嚼烟使用者生活在南亚地区。2019年,15至19岁年轻人中,有七个地区的使用率超过10%。尽管1990年至2019年期间全球年龄标准化吸烟率显著下降(年化变化率:-1.21%[-1.26%至-1.16%]),但嚼烟方面未观察到类似进展(0.46%[0.13%至0.79%])。在12个使用率最高的国家(孟加拉国、不丹、柬埔寨、印度、马达加斯加、马绍尔群岛、缅甸、尼泊尔、巴基斯坦、帕劳、斯里兰卡和也门)中,只有也门的嚼烟使用率显著下降,即1990年至2019年期间男性使用率下降了-0.94%[-1.72%至-0.14%],而12个国家中有9个国家的吸烟率显著下降。在女性中,这12个国家中没有一个国家的嚼烟使用率显著下降,而在该时期,12个国家中有7个国家的吸烟率显著下降。

解读

嚼烟在世界几个地区,主要是南亚,仍然是一个严重的公共卫生问题。我们发现1990年至2019年期间嚼烟使用率变化不大,并且在一些国家,控烟措施对吸烟率的影响比对嚼烟使用率的影响大得多。减轻嚼烟对健康的影响需要更强有力的法规和政策,特别是针对嚼烟使用的政策,尤其是在使用率高的国家。

资金来源

彭博慈善基金会和比尔及梅琳达·盖茨基金会。

相似文献

1
Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.1990 - 2019年204个国家和地区嚼烟使用流行情况的空间、时间和人口模式:来自《2019年全球疾病负担研究》的系统分析
Lancet Public Health. 2021 Jul;6(7):e482-e499. doi: 10.1016/S2468-2667(21)00065-7. Epub 2021 May 28.
2
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.1990-2015 年 195 个国家和地区的吸烟流行率和可归因疾病负担:来自 2015 年全球疾病负担研究的系统分析。
Lancet. 2017 May 13;389(10082):1885-1906. doi: 10.1016/S0140-6736(17)30819-X. Epub 2017 Apr 5.
3
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and initiation among young people in 204 countries and territories, 1990-2019.1990 - 2019年204个国家和地区年轻人吸烟流行率及开始吸烟情况的空间、时间和人口模式。
Lancet Public Health. 2021 Jul;6(7):e472-e481. doi: 10.1016/S2468-2667(21)00102-X. Epub 2021 May 28.
4
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年吸烟流行率、时空分布特征及归因疾病负担:基于 2019 年全球疾病负担研究的系统分析。
Lancet. 2021 Jun 19;397(10292):2337-2360. doi: 10.1016/S0140-6736(21)01169-7. Epub 2021 May 27.
5
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家 84 种行为、环境、职业和代谢风险以及 195 个国家和地区 1990 至 2017 年风险簇的比较风险评估:全球疾病负担研究 2017 系统分析。
Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8.
6
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.
7
The epidemiology and burden of smoking in countries of the Association of Southeast Asian Nations (ASEAN), 1990-2021: findings from the Global Burden of Disease Study 2021.1990 - 2021年东南亚国家联盟(东盟)各国吸烟的流行病学与负担:全球疾病负担研究2021的结果
Lancet Public Health. 2025 Jun;10(6):e442-e455. doi: 10.1016/S2468-2667(24)00326-8.
8
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.
9
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家 5 岁以下儿童死亡率、成人死亡率、特定年龄死亡率和预期寿命,1970-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1084-1150. doi: 10.1016/S0140-6736(17)31833-0.
10
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.

引用本文的文献

1
Global, Regional, and National Burden of Pharyngeal Cancer and Projections to 2050 in 185 Countries: A Population-Based Systematic Analysis of GLOBOCAN 2022.185个国家咽癌的全球、区域和国家负担以及到2050年的预测:基于全球疾病负担研究(GLOBOCAN)2022的人群系统分析
J Korean Med Sci. 2025 Aug 4;40(30):e177. doi: 10.3346/jkms.2025.40.e177.
2
Comparative analysis of tracheal, bronchus, and lung cancer burden trends between China and the global population (1990-2021).中国与全球人口气管、支气管和肺癌负担趋势的比较分析(1990 - 2021年)
J Thorac Dis. 2025 Jun 30;17(6):3772-3782. doi: 10.21037/jtd-2025-114. Epub 2025 Jun 25.
3

本文引用的文献

1
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年吸烟流行率、时空分布特征及归因疾病负担:基于 2019 年全球疾病负担研究的系统分析。
Lancet. 2021 Jun 19;397(10292):2337-2360. doi: 10.1016/S0140-6736(21)01169-7. Epub 2021 May 27.
2
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.
3
Disease burden and trends of bladder cancer in the world and BRICS from 1990 to 2021 and its projection until 2036: analysis based on the global burden of disease study 2021.
1990年至2021年全球及金砖国家膀胱癌的疾病负担、趋势及其至2036年的预测:基于2021年全球疾病负担研究的分析
Discov Oncol. 2025 Jul 12;16(1):1319. doi: 10.1007/s12672-025-03040-x.
4
Use of betel quid with and without tobacco and challenges to quitting among women attending a rural hospital in Sri Lanka.斯里兰卡一家乡村医院女性使用含烟草和不含烟草槟榔块的情况及戒烟面临的挑战
BMC Oral Health. 2025 Jul 1;25(1):966. doi: 10.1186/s12903-025-06338-y.
5
Global, regional, and national burden of laryngeal cancer in middle-aged and older adults from 1990 to 2021: an analysis of age and sex differences and attributable risk factors.1990年至2021年全球、区域和国家中老年成年人喉癌负担:年龄和性别差异及可归因风险因素分析
Front Public Health. 2025 May 30;13:1601029. doi: 10.3389/fpubh.2025.1601029. eCollection 2025.
6
The epidemiology and burden of smoking in countries of the Association of Southeast Asian Nations (ASEAN), 1990-2021: findings from the Global Burden of Disease Study 2021.1990 - 2021年东南亚国家联盟(东盟)各国吸烟的流行病学与负担:全球疾病负担研究2021的结果
Lancet Public Health. 2025 Jun;10(6):e442-e455. doi: 10.1016/S2468-2667(24)00326-8.
7
The Phase-Amplitude Coupling Changes Induced by Smoking Cue After 12-H Abstinence in Young Smokers.年轻吸烟者戒断12小时后吸烟线索诱发的相位-振幅耦合变化
Addict Biol. 2025 May;30(5):e70048. doi: 10.1111/adb.70048.
8
Global Burden of Lip and Oral Cavity Cancer From 1990 to 2021 and Projection to 2040: Findings From the 2021 Global Burden of Disease Study.1990年至2021年唇癌和口腔癌的全球负担及到2040年的预测:2021年全球疾病负担研究的结果
Cancer Med. 2025 May;14(9):e70957. doi: 10.1002/cam4.70957.
9
Salivary EGF: EGFR ratio as potential early diagnostic biomarker for oral cancer detection in tobacco chewers: a preliminary cross-sectional study.唾液表皮生长因子(EGF)与表皮生长因子受体(EGFR)的比值作为嚼烟者口腔癌检测的潜在早期诊断生物标志物:一项初步横断面研究。
BMC Oral Health. 2025 Apr 29;25(1):663. doi: 10.1186/s12903-025-05982-8.
10
A prospective study on diagnostic accuracy of technology-enabled early detection of oral cancer and epidemiology of tobacco and other substances use in rural India.一项关于印度农村地区借助技术手段早期检测口腔癌的诊断准确性以及烟草和其他物质使用流行病学的前瞻性研究。
Cancer. 2025 Jan 1;131(1):e35702. doi: 10.1002/cncr.35702.
Global burden of disease due to smokeless tobacco consumption in adults: an updated analysis of data from 127 countries.全球成年人因无烟烟草消费导致的疾病负担:来自 127 个国家数据的最新分析。
BMC Med. 2020 Aug 12;18(1):222. doi: 10.1186/s12916-020-01677-9.
4
Spatial Pattern and Determinants of Tobacco Use Among Females in India: Evidence From a Nationally Representative Survey.印度女性吸烟的空间模式和决定因素:一项全国代表性调查的证据。
Nicotine Tob Res. 2020 Dec 12;22(12):2231-2237. doi: 10.1093/ntr/ntaa137.
5
Dual Burden of Smoked and Smokeless Tobacco Use in India, 2009-2017: A Repeated Cross-Sectional Analysis Based on Global Adult Tobacco Survey.2009-2017 年印度吸烟和无烟烟草双重使用负担:基于全球成人烟草调查的重复横断面分析。
Nicotine Tob Res. 2020 Dec 12;22(12):2196-2202. doi: 10.1093/ntr/ntaa033.
6
Factors contributing to nass consumption among Iranian Turkmen: A qualitative study.伊朗土库曼人鼻烟消费的影响因素:一项定性研究。
Tob Induc Dis. 2018 Aug 27;16:37. doi: 10.18332/tid/93697. eCollection 2018.
7
Smokeless tobacco control in 180 countries across the globe: call to action for full implementation of WHO FCTC measures.全球 180 个国家的无烟烟草控制:呼吁全面实施世卫组织《烟草控制框架公约》措施。
Lancet Oncol. 2019 Apr;20(4):e208-e217. doi: 10.1016/S1470-2045(19)30084-1.
8
Feedback from vendors on ban in two States of India.印度两个邦的供应商的反馈意见。
Indian J Med Res. 2018 Jul;148(1):98-102. doi: 10.4103/ijmr.IJMR_121_18.
9
Determinants of smokeless tobacco use in India.印度无烟烟草使用的决定因素。
Indian J Med Res. 2018 Jul;148(1):41-45. doi: 10.4103/ijmr.IJMR_27_18.
10
Impact of the WHO FCTC on non-cigarette tobacco products.《世界卫生组织烟草控制框架公约》对非香烟烟草产品的影响。
Tob Control. 2019 Jun;28(Suppl 2):s104-s112. doi: 10.1136/tobaccocontrol-2018-054346. Epub 2018 Jul 31.